HomeVRAX • NASDAQ
add
Virax Biolabs Group Ltd
Previous close
$1.94
Day range
$1.91 - $2.10
Year range
$0.60 - $9.00
Market cap
8.19M USD
Avg Volume
3.36M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
MarketWatch
1 day ago
Nvidia and the Magnificent Seven make up too much of your high-priced index
fund
0.35%
3.22%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 2.48K | -93.52% |
Operating expense | 1.44M | 5.73% |
Net income | -1.38M | 5.27% |
Net profit margin | -55.64K | -1,362.89% |
Earnings per share | — | — |
EBITDA | -1.38M | -2.23% |
Effective tax rate | 4.72% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.29M | 39.97% |
Total assets | 9.44M | 34.41% |
Total liabilities | 1.03M | 11.64% |
Total equity | 8.42M | — |
Shares outstanding | 2.57M | — |
Price to book | 0.58 | — |
Return on assets | -38.11% | — |
Return on capital | -39.90% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.38M | 5.27% |
Cash from operations | -959.31K | 44.51% |
Cash from investing | -124.00K | 64.98% |
Cash from financing | 2.93M | 7,539.69% |
Net change in cash | 1.85M | 187.09% |
Free cash flow | -952.55K | 17.24% |
About
Founded
2013
Website
Employees
17
